Nuri F. Aykan

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis.

Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis.

Journal: Nigerian journal of clinical practice

Published: December 12, 2023

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.

Journal: Future oncology (London, England)

Published: August 30, 2022

The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer.

The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer.

Journal: Journal of gastrointestinal cancer

Published: October 19, 2020

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.

Journal: BMJ open

Published: March 30, 2020

Objective response rate assessment in oncology: Current situation and future expectations.

Objective response rate assessment in oncology: Current situation and future expectations.

Journal: World journal of clinical oncology

Published: May 05, 2019

Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients.

Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients.

Journal: Journal of gastrointestinal cancer

Published: January 06, 2018

Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study.

Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study.

Journal: Surgical oncology

Published: March 03, 2017

Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report.

Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report.

Journal: World journal of radiology

Published: January 27, 2017

Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer.

Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer.

Journal: Molecular and clinical oncology

Published: June 16, 2016

Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.

Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.

Journal: Journal of gastrointestinal cancer

Published: December 06, 2015

Red Meat and Colorectal Cancer.

Red Meat and Colorectal Cancer.

Journal: Oncology reviews

Published: August 15, 2015

Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.

Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 06, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026